in Paget’s disease of bone and its
response to diphosphonate treatment., Arthritis
Rheum., 31, 1142-1147 (1988).
Trasylol is a registered trademark of Bayer AG.
AH,PHC 02/05-1
295, 813-818 (2002).
3. Bromberg, J., STAT proteins and oncogenesis., J.
Clin. Invest. 109,1139-1142 (2002).
4. Ghislain, J.J., et al., The interferon-inducible
STAT2:STAT1 heterodimer preferentially
Substrate (Human
insulin receptor fragment (1142-1153))
P 6462 Protein Tyrosine Phosphatase Substrate
Monophosphate ([pTyr1146]-Insulin receptor
fragment (1142-1153))
S 2938 SC-ααδ9 (cdc25A protein
finger nuclease-
driven transgenesis into a safe harbor locus in
the human genome. Genome Res, 20, 1133-
1142 (2010).
3. Moehle, E.A., et al., Targeted gene addition into
a specified location in the
2.28 IP 2.23 New MAT Chapter
Due out in 2018 (Alternative)
CHP (China) Vol 1 General Principles 1142
Rev 2015
Chapter (not yet translated)
Rev 2015
N/A
References
1. Milton AS. Pyretics and
finger nuclease-driven transgenesis
into a safe harbor locus in the human genome.
Genome Res, 20, 1133-1142.
3. Moehle, E.A., Rock, J.M., Lee, Y.L., Jouvenot,
Y., DeKelver, R.C., Gregory, P.D., Urnov
nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res. 2010
;20(8):1133-1142.
4. Donnelly ML, Hughes LE, Luke G, Mendoza H, Dam ET, Gani D, Ryan MD (2001) The ‘cleavage